Intravenous zanamivir for influenza myocarditis and enteral malabsorption

Crit Care. 2018 Dec 4;22(1):332. doi: 10.1186/s13054-018-2263-y.

Authors

Fritz-Patrick Jahns¹, Nawfel Ben-Hamouda², Matthias Kirsch³, Aurélien Roumy³, Lucas Liaudet¹

Affiliations

¹ Department of Intensive Care Medicine and Burns, Lausanne University Hospital Medical Center, CHUV, 1011, Lausanne, Switzerland.
² Department of Intensive Care Medicine and Burns, Lausanne University Hospital Medical Center, CHUV, 1011, Lausanne, Switzerland. nawfel.ben-hamouda@chuv.ch.
³ Department of Cardiovascular Surgery, Lausanne University Hospital Medical Center, 1011, Lausanne, Switzerland.

No abstract available

Keywords: Drug malabsorption; Extracorporeal life support; Influenza; Myocarditis.

Publication types

Letter

MeSH terms

Administration, Intravenous
Adult
Antiviral Agents / therapeutic use
Catecholamines / therapeutic use
Female
Humans
Influenza, Human / complications*
Malabsorption Syndromes / etiology*
Middle Aged
Myocarditis / etiology*
Oseltamivir / therapeutic use
Zanamivir / therapeutic use*

Substances

Antiviral Agents
Catecholamines
Oseltamivir
Zanamivir